Related references
Note: Only part of the references are listed.Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer
Hara Polioudaki et al.
BMC CANCER (2015)
Genomic profiling of breast cancers
Christina Curtis
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2015)
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities
Stephane Terry et al.
ONCOTARGET (2015)
Biology, detection, and clinical implications of circulating tumor cells
Simon A. Joosse et al.
EMBO MOLECULAR MEDICINE (2015)
HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition
Danilo Ranieri et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Tumor Vasculature Is Regulated by FGF/FGFR Signaling-Mediated Angiogenesis and Bone Marrow-Derived Cell Recruitment: This Mechanism Is Inhibited by SSR128129E, the First Allosteric Antagonist of FGFRs
Pierre Fons et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
Marta Pestrin et al.
MOLECULAR ONCOLOGY (2015)
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
Rhonda L. Bitting et al.
CANCER AND METASTASIS REVIEWS (2014)
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?
Francesca Bedussi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer
Simona Carnio et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2014)
Circulating tumor cells detection has independent prognostic Lipact in high-risk non-muscle invasive bladder cancer
Paola Gazzaniga et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer
Lorena Alonso-Alconada et al.
MOLECULAR CANCER (2014)
Context-dependent adaption of EpCAM expression in early systemic esophageal cancer
C. Driemel et al.
ONCOGENE (2014)
Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
Ramdane Harouaka et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Biosensors for the Detection of Circulating Tumour Cells
Clotilde Costa et al.
SENSORS (2014)
Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression
Dong-Yuan Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
Maria J. Serrano et al.
ONCOTARGET (2014)
Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment
Laura Muinelo-Romay et al.
CANCERS (2014)
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
Maryam B. Lustberg et al.
BREAST CANCER RESEARCH (2014)
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
Sandra V. Fernandez et al.
BREAST CANCER RESEARCH (2014)
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
Yibin Kang et al.
CANCER CELL (2013)
Fibroblast Growth Factor Receptors-1 and-3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
Tiewei Cheng et al.
PLOS ONE (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Lixin Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
Agnieszka Martowicz et al.
BMC CANCER (2012)
ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas
E. Colas et al.
ONCOGENE (2012)
Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer
Jorge Barbazan et al.
PLOS ONE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Circulating tumor cells as emerging tumor biomarkers in breast cancer
Evi S. Lianidou et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
Stephen D. Mikolajczyk et al.
JOURNAL OF ONCOLOGY (2011)
EpCAM in carcinogenesis: the good, the bad or the ugly
Bernardina T. F. van der Gun et al.
CARCINOGENESIS (2010)
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer
Tetsuya Mitsudomi et al.
FEBS JOURNAL (2010)
Molecular Biomarker Analyses Using Circulating Tumor Cells
Elizabeth A. Punnoose et al.
PLOS ONE (2010)
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
Sharon Barr et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Micrometastatic disease in breast cancer: Clinical implications
Michail Igntiadis et al.
EUROPEAN JOURNAL OF CANCER (2008)
Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy
Souichi Yanamoto et al.
ORAL ONCOLOGY (2007)
ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 in endometrial cancer
Marta Monge et al.
CANCER RESEARCH (2007)
iTARGET: A phase II trial to assess the response to gefitinib in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) tumors
L. V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer
Lecia V. Sequist et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Loss of membranous Ep-CAM in budding colorectal carcinoma cells
Marleen J. E. M. Gosens et al.
MODERN PATHOLOGY (2007)
Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer
U Woelfle et al.
CLINICAL CANCER RESEARCH (2004)
Magnetic polystyrene nanoparticles with a high magnetite content obtained by miniemulsion processes
LP Ramírez et al.
MACROMOLECULAR CHEMISTRY AND PHYSICS (2003)
Share Paper
